<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: platinum</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Tiny genetic variation can predict ovarian cancer outcome</title>
   	 <description>Yale Cancer Center researchers have shown that a tiny genetic variation predicts chances of survival and response to treatment for patients with ovarian cancer.</description>
     <link>http://medicalxpress.com/news/2011-12-tiny-genetic-variation-ovarian-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 05 Dec 2011 07:20:34 EST</pubDate>
	 <guid isPermaLink="false">news242292012</guid>
	 
</item>
<item>
     <title>Popular colorectal cancer drug may cause permanent nerve damage</title>
   	 <description>(Medical Xpress) -- Oxaliplatin, a platinum-based anticancer drug that&amp;#146;s made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends. The chemotherapy side effect, described by Johns Hopkins researchers in the September issue of Neurology, was discovered in what is believed to be the first effort to track oxaliplatin-based nerve damage through relatively cheap and easy punch skin biopsies.</description>
     <link>http://medicalxpress.com/news/2011-09-popular-colorectal-cancer-drug-permanent.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 28 Sep 2011 09:20:01 EST</pubDate>
	 <guid isPermaLink="false">news236417447</guid>
	 
</item>


</channel>
</rss>
